Update on neonatal hypoglycemia

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 21, Issue 1, 2014, Pages 45-50

  Rozance, Paul J ^a  

^a Perinatal Research Center   (United States)

Author keywords

glucose; hyperinsulinism; insulin; neonatal hypoglycemia

Indexed keywords

GLUCOSE; INSULIN;

BLOOD GLUCOSE MONITORING; BRAIN INJURY; DISEASE ASSOCIATION; GENETIC ASSOCIATION; HIGH RISK PATIENT; HUMAN; HYPERINSULINISM; HYPOGLYCEMIA; INCIDENCE; METABOLIC DISORDER; NEWBORN DISEASE; PREMATURITY; REVIEW; SMALL FOR DATE INFANT;

BIOSENSING TECHNIQUES; BLOOD GLUCOSE; DEVELOPMENTAL DISABILITIES; DIAZOXIDE; DIURETICS; FEMALE; GLUCOSE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERINSULINISM; HYPOGLYCEMIA; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MONITORING, PHYSIOLOGIC; POTASSIUM CHLORIDE; VASODILATOR AGENTS;

EID: 84892368476     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000027     Document Type: Review

References (62)

1. Koh TH, Eyre JA, Aynsley-Green A. Neonatal hypoglycaemia-The controversy regarding definition. Arch Dis Child 1988; 63: 1386-1388
2. Rozance PJ, Hay WW. Hypoglycemia in newborn infants: Features associated with adverse outcomes. Biol Neonate 2006; 90: 74-86
3. American Academy of Pediatrics Committee on Fetus and Newborn: Routine evaluation of blood pressure, hematocrit, and glucose in, newborns. Pediatrics 1993; 92: 474-476
4. Adamkin DH. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics 2011; 127: 575-579
5. Harris DL, Weston PJ, Harding JE. Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr 2012; 161: 787-791
6. Maayan-Metzger A, Lubin D, Kuint J. Hypoglycemia rates in the first days of life among term infants born to diabetic mothers. Neonatology 2009; 96: 80-85
7. Pildes R, Forbes AE, O'Connor SM, et al. The incidence of neonatal hypoglycemia-A completed survey. J Pediatr 1967; 70: 76-80
8. Sexson WR. Incidence of neonatal hypoglycemia: A matter of definition. J Pediatr 1984; 105: 149-150
9. Agrawal RK, Lui K, Gupta JM. Neonatal hypoglycaemia in infants of diabetic mothers. J Paediatr Child Health 2000; 36: 354-356
10. Hume R, McGeechan A, Burchell A. Failure to detect preterm infants at risk of hypoglycemia before discharge. J Pediatr 1999; 134: 499-502
11. Flores-le Roux JA, Sagarra E, Benaiges D, et al. A prospective evaluation of neonatal hypoglycaemia in infants of women with gestational diabetes mellitus. Diabetes Res Clin Pract 2012; 97: 217-222
12. Ramos GA, Hanley AA, Aguayo J, et al. Neonatal chemical hypoglycemia in newborns from pregnancies complicated by type 2 and gestational diabetes mellitus-The importance of neonatal ponderal index. J Matern Fetal Neonatal Med 2012; 25: 267-271
13. Garcia-Patterson A, Aulinas A, Maria MA, et al. Maternal body mass index is a predictor of neonatal hypoglycemia in gestational diabetes mellitus. J Clin Endocrinol Metab 2012; 97: 1623-1628
14. Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 2011; 204: 479-487
15. Tundidor D, Garcia-Patterson A, Maria MA, Ubeda J, et al. Perinatal maternal and neonatal outcomes in women with gestational diabetes mellitus according to fetal sex. Gend Med 2012; 9: 411-417
16. Bracero LA, Cassidy S, Byrne DW. Effect of gender on perinatal outcome in pregnancies complicated by diabetes. Gynecol Obstet Invest 1996; 41: 10-14
17. Weissmann-Brenner A, Simchen MJ, Zilberberg E, et al. Maternal and neonatal outcomes of large for gestational age pregnancies. Acta Obstet Gynecol Scand 2012; 91: 844-849
18. Maayan-Metzger A, Leibovitch L, Schushan-Eisen I, et al. Meconium-stained amniotic fluid and hypoglycemia among term newborn infants. Fetal Pediatr Pathol 2012; 31: 283-287
19. Ngerncham S, Piriyanimit S, Kolatat T, et al. Validity of two point of care glucometers in the diagnosis of neonatal hypoglycemia. Indian Pediatr 2012; 49: 621-625
20. Scott MG, Bruns DE, Boyd JC, et al. Tight glucose control in the intensive care unit: Are glucose meters up to the task? Clin Chem 2009; 55: 18-20
21. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, et al. Validation of the continuous glucose monitoring sensor in preterm infants. Arch Dis Child Fetal Neonatal Ed 2013; 98: F136-F140
22. Beardsall K, Ogilvy-Stuart AL, Ahluwalia J, et al. The continuous glucose monitoring sensor in neonatal intensive care. Arch Dis Child Fetal Neonatal Ed 2005; 90: F307-F310
23. Harris DL, Battin MR, Weston PJ, et al. Continuous glucose monitoring in newborn babies at risk of hypoglycemia. J Pediatr 2010; 157: 198-202
24. Signal M, Le CA, Harris DL, et al. Impact of retrospective calibration algorithms on hypoglycemia detection in newborn infants using continuous glucose monitoring. Diabetes Technol Ther 2012; 14: 883-890
25. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, et al. Early insulin therapy in very-low-birth-weight infants. N Engl J Med 2008; 359: 1873-1884
26. Arya VB, Flanagan SE, Kumaran A, et al. Clinical and molecular characterisation of hyperinsulinaemic hypoglycaemia in infants born small-for-gestational age. Arch Dis Child Fetal Neonatal Ed 2013; 98: F356-F358
27. Hoe FM, Thornton PS, Wanner LA, et al. Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism. J Pediatr 2006; 148: 207-212
28. Al-Otaibi H, Senniappan S, Alam S, et al. Biochemical studies in patients with hyperinsulinaemic hypoglycaemia. Eur J Pediatr 2013; 172: 1435-1440
29. Fafoula O, Alkhayyat H, Hussain K. Prolonged hyperinsulinaemic hypoglycaemia in newborns with intrauterine growth retardation. Arch Dis Child Fetal Neonatal Ed 2006; 91: F467
30. Collins JE, Leonard JV, Teale D, et al. Hyperinsulinaemic hypoglycaemia in small for dates babies. Arch Dis Child 1990; 65: 1118-1120
31. Gataullina S, Dellatolas G, Perdry H, et al. Comorbidity and metabolic context are crucial factors determining neurological sequelae of hypoglycaemia. Dev Med Child Neurol 2012; 54: 1012-1017
32. Gataullina S, De LP, Dellatolas G, et al. Topography of brain damage in metabolic hypoglycaemia is determined by age at which hypoglycaemia occurred. Dev Med Child Neurol 2013; 55: 162-166
33. Christesen HT, Brusgaard K, Hussain K. Recurrent spontaneous hypoglycaemia causes loss of neurogenic and neuroglycopaenic signs in infants with congenital hyperinsulinism. Clin Endocrinol [Oxf] 2012; 76: 548-554
34. Faletra F, Snider K, Shyng SL, et al. Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: Clinical and functional characterization of two novel ABCC8 mutations. Gene 2013; 516: 122-125
35. Stanescu DE, Hughes N, Kaplan B, et al. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab 2012; 97: E2026-E2030
36. Flanagan SE, Xie W, Caswell R, et al. Next-generation sequencing reveals deep intronic cryptic ABCC8 and HADH splicing founder mutations causing hyperinsulinism by pseudoexon activation. Am J Hum Genet 2013; 92: 131-136
37. Henquin JC, Sempoux C, Marchandise J, et al. Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-Activating mutation in a subset of beta-cells. Diabetes 2013; 62: 1689-1696
38. Pinney SE, Ganapathy K, Bradfield J, et al. Dominant form of congenital hyperinsulinism maps to HK1 region on 10q. Horm Res Paediatr 2013; 80: 18-27
39. Snider KE, Becker S, Boyajian L, et al. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab 2013; 98: E355-E363
40. Kapoor RR, Flanagan SE, Arya VB, et al. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol 2013; 168: 557-564
41. De LP, Fournet JC, Rahier J, et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997; 100: 802-807
42. Kapoor RR, Flanagan SE, Ellard S, et al. Congenital hyperinsulinism: Marked clinical heterogeneity in siblings with identical mutations in the ABCC8 gene. Clin Endocrinol [Oxf] 2012; 76: 312-313
43. Mercimek-Mahmutoglu S, Horvath GA, Coulter-Mackie M, et al. Profound neonatal hypoglycemia and lactic acidosis caused by pyridoxine-dependent epilepsy. Pediatrics 2012; 129: E1368-e1372
44. Hu S, Xu Z, Yan J, et al. The treatment effect of diazoxide on 44 patients with congenital hyperinsulinism. J Pediatr Endocrinol Metab 2012; 25: 1119-1122
45. Demirel F, Unal S, Cetin II, et al. Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide. J Pediatr Endocrinol Metab 2011; 24: 603-605
46. Nebesio TD, Hoover WC, Caldwell RL, et al. Development of pulmonary hypertension in an infant treated with diazoxide. J Pediatr Endocrinol Metab 2007; 20: 939-944
47. Calabria AC, Li C, Gallagher PR, et al. GLP-1 receptor antagonist exendin-[9-39] elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K channel. Diabetes 2012; 61: 2585-2591
48. Huang T, Kelly A, Becker SA, et al. Hypertrophic cardiomyopathy in neonates with congenital hyperinsulinism. Arch Dis Child Fetal Neonatal Ed 2013; 98: F351-F354
49. Hay WW Jr. Care of the infant of the diabetic mother. Curr Diab Rep 2012; 12: 4-15
50. Abu-Sulaiman RM, Subaih B. Congenital heart disease in infants of diabetic mothers: Echocardiographic study. Pediatr Cardiol 2004; 25: 137-140
51. Arnoux JB, Verkarre V, Saint-Martin C, et al. Congenital hyperinsulinism: Current trends in diagnosis and therapy. Orphanet J Rare Dis 2011; 6: 63
52. Blomberg BA, Moghbel MC, Saboury B, et al. The value of radiologic interventions and [18] F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: Systematic review and meta-Analysis. Mol Imaging Biol 2013; 15: 97-105
53. Laje P, States LJ, Zhuang H, et al. Accuracy of PET/CT Scan in the diagnosis of the focal formof congenital hyperinsulinism. J Pediatr Surg 2013; 48: 388-393
54. Meintjes M, Endozo R, Dickson J, et al. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: Initial UK experience from a technologist's perspective. Nucl Med Commun 2013; 34: 601-608
55. Laje P, Stanley CA, Palladino AA, et al. Pancreatic head resection and Rouxen-Y pancreaticojejunostomy for the treatment of the focal form of congenital hyperinsulinism. J Pediatr Surg 2012; 47: 130-135
56. Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ 1988; 297: 1304-1308
57. Cornblath M, Schwartz R. Outcome of neonatal hypoglycaemia. Complete data are needed. BMJ 1999; 318: 194-195
58. Tin W, Brunskill G, Kelly T, et al. 15-year follow-up of recurrent 'hypoglycemia'in preterm infants. Pediatrics 2012; 130: E1497-e1503
59. Kerstjens JM, Bocca-Tjeertes IF, de Winter AF, et al. Neonatal morbidities and developmental delay in moderately preterm-born children. Pediatrics 2012; 130: E265-e272
60. McIntyre S, Taitz D, Keogh J, et al. A systematic review of risk factors for cerebral palsy in children born at term in developed countries. Dev Med Child Neurol 2013; 55: 499-508
61. Tam EW, Haeusslein LA, Bonifacio SL, et al. Hypoglycemia is associated with increased risk for brain injury and adverse neurodevelopmental outcome in neonates at risk for encephalopathy. J Pediatr 2012; 161: 88-93
62. Boluyt N, van Kempen KA, Offringa M. Neurodevelopment after neonatal hypoglycemia: A systematic review and design of an optimal future study. Pediatrics 2006; 117: 2231-2243